Biotech Values

[dewophile]

Yes; however, the HBs seroconverion makes an off-therapy relapse considerably less likely than merely having undetectable HBsAg at the end of treatment

my understanding is that the overwhelming majority who get to undetectable seroconvert so the fact these patients have surface antibodies vs merely loss of surface antigen is relatively meaningless